AWARD
A -- Award Notice: Performance of Good Clinical Practices (GCP) Compliant Phase II Clinical Trial of a Valproic Acid Product for Treatment of Patients with Significant Hemorrhage
- Notice Date
- 9/11/2015
- Notice Type
- Award Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH15R0019
- Response Due
- 6/12/2015
- Archive Date
- 10/11/2015
- Point of Contact
- Wayne Medina, 301-619-9204
- E-Mail Address
-
US Army Medical Research Acquisition Activity
(wayne.a.medina2.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Award Number
- W81XWH-15-C-0128
- Award Date
- 9/10/2015
- Awardee
- WESTAT, INC. (049508120) <br> 1600 RESEARCH BLVD <br> ROCKVILLE, MD 20850
- Award Amount
- $12,136,555.00
- Line Number
- 0001-0009
- Description
- This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2). Westat Inc., Rockville, Maryland, was awarded a $12,136,555 cost-plus-fixed-fee contract with options to develop and license valproic acid for the treatment of patients with significant hemorrhage.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH15R0019/listing.html)
- Record
- SN03883407-W 20150913/150912000712-bb247f89b09c68554775c29fb6f3d556 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |